Department of Immunology and Microbial Science
Faculty, Graduate Program
Our laboratory focuses on entry processes of enveloped viruses and the various ways that the innate and adaptive immune responses inhibit these processes. We also apply our insights toward developing therapeutic strategies that enhance or supplement these immune responses. Our work can be divided into three categories: (1) biochemical studies of the HIV-1 entry process and its inhibition, (2) identification and characterization of obligate factors, including receptors, necessary for the entry of other enveloped viruses, and (3) identification and characterization of host restriction factors that inhibit early steps in the viral life cycle, in particular those of the IFITM family.
A.B., Government, Harvard College, 1984
Ph.D., Immunology, Harvard Medical School, 1997
1993-1997 Graduate Student, Harvard Medical School (HMS)
1997-1999 Post-Doctoral Fellow, Department of Pathology, HMS
1999-2002 Instructor, Department of Pathology, HMS
2002-2004 Assistant Professor, Department of Medicine, HMS
2005-2007 Assistant Professor, Department of Microbiology and Molecular Genetics, HMS
2007-2012 Associate Professor, Department of Microbiology and Immunobiology, HMS
2012 Professor, Department of Microbiology and Immunobiology, HMS
2012- Professor, Department of Infectious Diseases, TSRI-Florida
Dana-Farber Cancer Institute Richard A. Smith Prize 2000
GlaxoSmithKline Drug Discovery and Developmental Research Award 2004
Burroughs Wellcome Fund Investigators in Pathogenesis Award 2007-2012
The Kavli Foundation and the National Academy of Sciences Kavli Fellowship 2008
Section Editor for Viral Pathogenesis, PLoS Pathogens
Member, NIH AIDS Molecular and Cellular Biology (AMCB) Study Section
Member, NIH Systems Biology Working Group (SBWG)
Steering Committee, Infectious Disease Initiative, Broad Institute
Editorial Board, Journal of Virology
Primary Publications (from >100)
Farzan M, Mirzabekov T, Kolchinsky P, Wyatt R, Cayabyab M, Gerard NP, Gerard C, Sodroski J, Choe H. Tyrosine sulfation of the amino-terminus of CCR5 facilitates HIV-1 entry. Cell. 1999; 96:667-76.
Choe H, Li W, Wright PL, Vasilieva N, Venturi M, Huang CC, Grundner C, Dorfman T, Zwick MB, Wang L, Rosenberg ES, Kwong PD, Burton DR, Robinson JE, Sodroski JG, Farzan M. Tyrosine sulfation of human antibodies contributes to recognition of the CCR5-binding region of HIV-1 gp120. Cell. 2003; 114:161-70.
Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC, Choe H, Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003; 426:450-4.
Li W, Zhang C, Sui J, Kuhn JH, Moore MJ, Luo S, Wong SK, Huang IC, Xu K, Vasilieva N, Murakami A, He Y, Marasco WA, Guan Y, Choe H, Farzan M. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 2005; 24:1634-43.
Li F, Li W, Farzan M, and Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005; 30:1864-8.
Radoshitzky SR, Abraham J, Spiropoulou CF, Kuhn JH, Nguyen D, Li W, Nagel J, Schmidt PJ, Nunberg JH, Andrews NC, Farzan M, Choe H. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature. 2007; 446:92-6.
Radoshitzky SR, Kuhn JH, Spiropoulou CF, Albariño CG, Nguyen DP, Salazar-Bravo J, Dorfman T, Lee AS, Wang E, Ross SR, Choe H, Farzan M. Receptor Determinants of Zoonotic Transmission of New World Hemorrhagic Fever Arenaviruses. Proc Natl Acad Sci U S A. 2008; 105:2664-9.
Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan B, JL. Weyer JL, van der Weyden L, Fikrig E, Adams DJ, Xavier RJ, Farzan M*, Elledge SJ. IFITM Proteins Mediate the Innate Immune Response to Influenza A H1N1 Virus, West Nile Virus and Dengue Virus. Cell. 2009; 139:1243-54. *co-corresponding
Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, Brass AL, Ahmed AA, Chi X, Dong L, Longobardi LE, Boltz D, Kuhn JH, Elledge SJ, Bavari S, Denison MR, Choe H, Farzan M. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog. 2011; 7:e1001258
Bailey CC, Huang IC, Kam C, Farzan M. Ifitm3 limit the severity of acute influenza in mice. PLoS Pathog 2012; 8:e1002809.
Reviews summarizing our work
Li W, Wong SK, Li F, Kuhn JH, Huang IC, Choe H, Farzan M. Animal Origins of SARS Coronavirus: Insight from ACE2/S-protein Interactions. J Virol. 2006; 80:4211-9.
Choe H and Farzan M. Tyrosine sulfation of HIV-1 coreceptors and other chemokine receptors. Methods Enzymol. 2009;461:147-70
Choe H, Jemielity S, Abraham J, Radoshitzky SR, Farzan M. Transferrin receptor 1 in the zoonosis and pathogenesis of New World hemorrhagic fever arenaviruses. Curr Opin Microbiol. 2011; 14:476-82.
Diamond MS and Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol. 2013; in press.